Navigation Links
Breakthrough isolating embryo-quality stem cells from blood

A major breakthrough in stem cell research ?a new tool that could allow scientists to harvest stem cells ethically - will be announced at the Institute of Physics' conference Physics 2005 in Warwick later today (Tuesday 12th April).

Professor Josef Käs and Dr Jochen Guck from the University of Leipzig have developed a procedure that can extract and isolate embryo-quality stem cells from adult blood for the first time. This new technique could unlock the stem cell revolution and stimulate a boom in medical research using stem cells.

Stem cells are cells which have not yet differentiated into specialised tissues such as skin, brain or muscle. They promise a new class of regenerative medicine, which could repair apparently permanent damage such as heart disease or Parkinson's. The cells are currently taken from aborted human foetuses, an issue which has led to controversy and opposition in many parts of the world. Any alternative source, such as voluntary adult donations, could spark a boom in new cures.

Scientists have known for some time that stem cells exist in adult human blood and certain other tissues. However the only reliable way to separate them involved marking the cells with a chemical dye, rendering them useless for medical purposes. Professor Käs' technique for the first time uses a physical characteristic of each cell ?its stretchiness or elasticity ?instead of its biological make-up, to decide whether or not it's a stem cell. Stem cells don't need a rigid "cytoskeleton" to hold them in shape, which makes them stretchier than normal cells.

Käs and Guck's machine uses a powerful beam of infrared laser light to stretch and measure cells one by one. His optical stretcher differs from an existing tool known as optical tweezers in which the light is focused to a sharp point to grab hold of a cell. In contrast, the optical stretcher uses un-focused light. This allows laser beams strong enough to detect stretching to be used withou t killing the cell.

According to Dr Michael Watts, an expert in haematology and stem cells at University College London, there are just 10,000 primitive cells in the average adult's bloodstream. Of those, only 500 might have the potential to replace embryonic stem cells. Stem cell research requires millions of these cells.

Bone marrow donors are routinely treated with a drug known as G-CSF which "mobilises" stem cells from the bone marrow into the blood. After G-CSF treatment the donor's blood is passed through a centrifuge and back into their body, akin to a kidney dialysis machine, harvesting two or three hundred million primitive cells in the process.

Various properties of these primitive cells have been used to try and isolate the 5% or so with the highest stem cell potential, but no single technology has proved completely successful for human stem cells. This is where the optical stretcher could come to the rescue, picking those cells one by one according to the strength of their cytoskeletons. Watts explains that such an advance could have far-reaching consequences for medical treatments. "We could add significantly to our knowledge of stem cell biology toward developing cellular therapies," he says.

The optical stretcher can already test 3,600 cells per minute. This is not yet fast enough for industrial separation of millions of high grade stem cells, but it promises a realistic alternative to embryo use if it can be scaled up. Meanwhile, it is already being used to isolate low-grade stem cells which can develop into skin. In collaboration with medical professionals in Leipzig, elderly patients are being treated for persistent non-healing wounds. Low-grade stem cells isolated from the patient's own blood are applied to the wound to kick-start the healing process.


'"/>

Source:Institute of Physics


Related biology news :

1. Breakthrough Microarray-based Technology for the Study of Cancer
2. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
3. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
4. Breakthrough System for Understanding Ocean Plant Life Announced
5. Breakthrough: Scientists create worlds tiniest organic particles
6. Breakthrough in micro-device fabrication combines biology and synthetic chemistry
7. Sciences Breakthrough of the Year: Watching evolution in action
8. Breakthrough for stem cell research
9. Breakthrough in understanding type-2 diabetes as key genes identified
10. Breakthrough vaccine to treat chemo-resistant ovarian cancer
11. Wisconsin scientists grow critical nerve cells
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... SAN FRANCISCO and BANGALORE, India ... part of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... service provider, today announced a global partnership that ... convenient way to use mobile banking and payment services. ... Mobility is a key innovation area for financial services, but ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , ... June 23, 2016 , ... STACS DNA Inc., ... Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field ... DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
Breaking Biology Technology: